Today

Biogen Financial News

All news where Biogen is mentioned

The first pill to treat postpartum depression has been approved by US health officials

The first pill to treat postpartum depression has been approved by US health officials

US FDA approves Biogen-Sage Therapeutics pill for postpartum depression

US FDA approves Biogen-Sage Therapeutics pill for postpartum depression

Pill for postpartum depression can help new mothers boost their mental well-being

Pill for postpartum depression can help new mothers boost their mental well-being

FDA approves breakthrough pill for severe postpartum depression in new mothers

FDA approves breakthrough pill for severe postpartum depression in new mothers

FDA approves first postpartum depression pill

FDA approves first postpartum depression pill

4 big deal reports: Biogen shells out $7.3B for Reata Pharma

4 big deal reports: Biogen shells out $7.3B for Reata Pharma

Stocks making the biggest moves midday: Intel, Roku, Sweetgreen, Ford & more

Stocks making the biggest moves midday: Intel, Roku, Sweetgreen, Ford & more

Biogen to bulk up rare disease treatments with $7 billion Reata acquisition

Biogen to bulk up rare disease treatments with $7 billion Reata acquisition

Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more

Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more

Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio

Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio

Stocks making the biggest moves midday: Spotify, RTX, General Electric and more

Stocks making the biggest moves midday: Spotify, RTX, General Electric and more

Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial

Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial

New cancer-like rating system introduced for Alzheimer's diagnosis

New cancer-like rating system introduced for Alzheimer's diagnosis

Acumen's Alzheimer's drug passes initial safety test

Acumen's Alzheimer's drug passes initial safety test

Alzheimer's diagnosis revamp embraces rating scale similar to cancer

Alzheimer's diagnosis revamp embraces rating scale similar to cancer

FDA’s OK Isn’t Always a Happy Day for Biotech Investors

FDA’s OK Isn’t Always a Happy Day for Biotech Investors

Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more

Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more

Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug

Factbox-Companies in Alzheimer's race after US nod for Eisai/Biogen drug

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more

Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more

Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?

Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?

Prev
1
2
3
Next

About Us

Fvbb.com is an aggregator of the latest financial news in your feed. Be the first to know everything concerning financial analyzes, currency, world economy, investments and even much more. The latest financial news from the leading news agencies around the world at one place for your comfort. 300+ information resources are here on our site, that give you the opportunity to save time on search. Just actual news 24/7 non-stop! Stay tuned and we will keep you informed!

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories

Info

For advertisers

Advertising Questions ?

Add news

Add Source

©2024. All rights reserved.

DMCA